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Abstract: Dibenz[b,f]azepine and its five derivatives bearing different functional 
groups were synthesized by  known methods. The compounds thus synthesized 
were evaluated for antioxidant potential through different in vitro models such as 
(DPPH) free radical scavenging activity, β-carotene-linoleic acid model system, 
reducing power assay and phosphomolybdenum method. Under our experimental 
condition among the synthesized compounds dibenz[b,f]azepine (a) and 10-
methoxy-5H-dibenz[b,f]azepine (d) exhibited potent antioxidant activity in 
concentration dependent manner in all the above four methods. Butylated 
hydroxyl anisole (BHA) and ascorbic acid (AA) were used as the reference 
antioxidant compounds. The most active compounds like dibenz[b,f]azepine and 
its methoxy group substituent have shown more promising antioxidant and 
radical scavengers compared to the standards like BHA and ascorbic acid. It is 
conceivable from the studies that the tricyclic amines, i.e. dibenz[b, f]azepine and 
some of its derivatives are effective in their antioxidant activity properties. 
Keywords: Dibenz[b,f]azepine, Antioxidant activity, Radical scavenging activity, β-Carotene-linoleic 
acid, Reducing power, Phosphomolybdenum. 
Introduction 
Free radicals can have a noxious effect on cells, and it is believed that free radical damage is 
involved in the etiology of several diseases. Free radicals are being formed during normal 
cellular metabolism and they are known to contribute to healthy functions in human health 
and development when they are not excessive. Formation of free radicals is not limited to 
normal cellular process but also occurs upon exposure to certain chemicals (polycyclic 
aromatic hydrocarbon, cadmium, lead, etc.), radiation, cigarette smoke, and high fat diet. A 
balance between formation of free radicals and their  detoxification  is  essential  for  normal 
cellule function. When such a balance  is  disrupted  as a  result  of  excessive  generation  of  
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damaging species or low levels of antioxidants, a cell enters a state of oxidative stress and is 
damaged. If the damage persists the cell will enter a state of genetic instability that can lead 
to chronic diseases including cancer1. A series of compounds that can scavenge radicals by 
trapping initiating and/or propagating radicals, thus called ‘antioxidant’2. In biological 
systems, the definition for antioxidants has been extended to any substance that when 
present at low concentrations compared to those of an oxidisable substrate, significantly 
delays or prevents oxidation of that substrate3.  
 Antioxidants protect against these radicals, and it is important to balance an enhanced 
radical production with a sufficient supply of antioxidants. Numerous natural and synthetic 
antioxidant compounds have been tested with success in various disease models as well as in 
clinics4. In vivo production of excess free radicals plays a role in several human diseases. 
Septic shock, triggered by bacterial endotoxins, is linked to radical-induced tissue, which 
leads to pulmonary and cardiac collapse and even to death5. 
 In the literature some tricyclic amines and their chemical structure shows antioxidant 
neuroprotective activity in vitro6. Now a day, the free-radical scavenging mechanism of 
aromatic amines (Ar2NHs) has been discussed from the view of chemical kinetics7. 
 Dibenz[b,f]azepine and its derivatives has been variously reported as having antiallergic 
activity, specifically antihistaminic activity, spansmolytic, serotonin antagonistic, 
anticonvulsive, antiemetic, antiepileptic, anti-inflammatory, sedative and fungicidal action10. 
5H-dibenz[b,f]azepine is a common basic fused tricyclic tertiary amine, related to a class of 
anticonvulsants which are employed in the prevention or the treatment of epileptic seizures 
and bipolar disorders. This nucleus has been known since 1899, when Thiele and Holzinger 
prepared 10,11-dihydro dibenz[b,f]azepine6.The approved (chemical abstracts) numbering of 
the ring positions of 5H-dibenz[b,f]azepine  is as shown in Figure 1. 
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Figure 1. Numbering of the ring position of 5H-dibenz[b,f]azepine. 
 5H-Dibenz[b,f]azepine is useful for various therapeutics such as carbamazepine, 
oxcarbamazepine etc7. 
 The research on antioxidants provides theoretical information for the medicinal 
development, and supplies some in vitro methods for quick-optimizing drugs, it attracts more 
scientific attention from bioorganic and medicinal chemists. In addition to the traditional O-H 
bond type antioxidant, tricyclic amines having N-H bond functions as the antioxidant have 
attracted much research attention because Ar2NHs have always been the central structure in 
many currently used drugs. Since their structure may justify a possible intervention on free 
radical process, so this study has been taken to explore better the chemistry and biological 
activities of dibenz[b,f]azepine and its derivatives. Six known molecules, numbering a to f 
were synthesized and their structure was established by chemical and spectral analysis. The 
compounds were investigated for in vitro antioxidant potential and compared to commercially 
available synthetic antioxidants namely BHA and ascorbic acid. 
Experimental 
Melting points of the compounds were determined  by  the  open  capillary  method  and  are 
uncorrected. The IR spectra were recorded on  a FT-IR021 model in KBr  disc  and  in  nujol 
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mull. The 1H NMR spectra were recorded on Jeol-60MHz and Jeol GSX 400MHz 
spectrophotometer using CDCl3 as a solvent and TMS as an internal reference. The chemical 
shifts are expressed in δ (ppm) values. The Mass spectra were recorded on Hitachi RMU-61 
spectrophotometer and important fragments are given with percentage of abundance in the 
bracket. The purity of the compounds was checked by thin layer chromatography on silica 
gel glass plates in hexane and ethyl acetate solvent mixture (9:1 v/v). The compounds were 
purified by column chromatography on silica gel (60-120 mesh) bed as adsorbent and 
hexane and ethyl acetate as eluent.  
 
Reaction Scheme 1. 
General procedure for the preparation of dibenz[b,f]azepine and its five derivatives11. 
Dibenz[b,f]azepine (Compound a) 
Dibenz[b,f]azepine was prepared by coupling of nitro tolune in presence of basic catalyst to 
form bibenzyl (o,o' dinitroazepine). This is reduced to give 10,11-dibenz[b,f]azepine (1) 
further upon dehydrogenation yielded Dibenz[b,f]azepine. 
5H-Dibenz[b,f]azepine-5-carboxamide (Compound b) 
Dibenz[b,f]azepine (1.93 g, 10 mM) was refluxed in the  presence of COCl2 with strong base 
(NaNH3 )  to get  chloro carbonyl dibenz[b,f]azepine (10 mM, 0.253 g), which upon further 
reflux with concentrated ammonia (25 mL) to give product. 
1-DIbenz[b,f]azepine 5yl) ethanone (Compound c)  
5H-dibenz[b,f]azepine 5yl) ethanone was prepared by refluxing 5H-dibenz[b,f]azepine   
(1.93 g, 10 mM) in acetic anhydride (25 mL) for 6h. 
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10-Methoxy-5H-dibenz[b,f azepine (Compound d) 
10-Methoxy-5H-dibenz[b,f]azepine was prepared by brominating N-acetyl-5H-dibenz[b,f] 
azepine (2.35 g, 10 mM) using bromine (3.2 g, 20 mM) in dichloromethane (25 mL) to 
obtain dibromo derivative, which was further refluxed with KOH (1.12 g, 20 mM) in 
CH3OH  (25 mL) to obtain the product. 
5-Chloro carbonyl-10,11-dihydro-5H-dibenz[b,f]azepine (Compound e)   
5-Chlorocarbonyl-10,11-dihydro-5H-dibenz[b,f]azepine obtained by refluxing dihydro-5H-dibenz 
[b,f]azepine (1.95g, 10 mM) with concentrated triphosgene (25 mL) in presence of dibase (NaNH2). 
1-(10,11-Dihydrobenz[b,f azepine 5yl) ethanone (Compound f)  
1-(10,11-Dihydrobenz[b,f]azepine 5yl) ethanone was prepared by refluxing 10,11-dihydro-
5H-dibenz[b,f]azepine (1.95 g, 10 mM) in acetic anhydride (25 mL) for 6h. 
Antioxidant studies 
In the present study, four commonly used antioxidant evaluation methods such as DPPH 
radical scavenging activity, β-carotene -linoleic acid model system, reducing power assay 
and phosphomolybdenum method were chosen to determine the antioxidant potential of the 
six compounds. The synthesized compounds were dissolved in distilled ethanol (50 mL) to 
prepare 1000 µM solution. Solutions of different concentrations (10 µM, 50 µM, 100 µM, 
200 µM and 500 µM) were prepared by serial dilution and the free radical scavenging 
activity and antioxidant activity evaluation were studied. 
DPPH radical scavenging activity 
The DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging effect was carried out 
according to the method first employed by Blois12. Compounds of different concentrations 
were prepared in distilled ethanol, 1 mL of each compound solutions having different 
concentrations (10 µM, 50 µM, 100 µM, 200 µM and 500 µM) were taken in different test 
tubes; 4 mL of a 0.1 mM ethanol solution of DPPH was added and shaken vigorously. The 
tubes were then incubated in the dark room at RT for 20 min.  A DPPH blank was prepared 
without compound, and ethanol was used for the baseline correction. Changes (decrease) in 
the absorbance at 517 nm were measured using a UV-visible spectrophotometer and the 
remaining DPPH was calculated. The percent decrease in the absorbance was recorded for 
each concentration, and percent quenching of DPPH was calculated on the basis of the 
observed decreased in absorbance of the radical. The radical scavenging activities were 
expressed as the inhibition percentage and were calculated using the formula: 
Radical scavenging activity (%) = [(A0 – A1 / A0 ×100] 
 Where A0 was the absorbance of the control (blank, without compound) and A1 was the 
absorbance of the compound. The radical scavenging activity of BHA and ascorbic acid was 
also measured and compared with that of the different synthesized compound. For all the 
compounds and standards half inhibition concentration (IC50) was calculated graphically 
using a linear regression algorithm. 
Antioxidant activity by β- carotene – linoleic acid assay 
Each compound at the final concentration of 50 µM/mL and 100 µM/mL were incorporated into 
β-carotene-linoleic acid model system independently and the activity was monitored 
spectrophotometrically at 470 nm13. 
Preparation of the suspension 
The  substrate  suspension  was  prepared  by  addition  of β-carotene   (4 mg dissolved in 5 mL 
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chloroform) into a covered round bottomed flask containing Tween- 40 (600 mg) followed by 
the addition of linoleic acid (60 µL). The chloroform was removed completely under vacuum 
using rotavapour at 400C. The resulting solution was diluted with triple distilled water (30 mL) 
and the emulsion was mixed well and the diluted with oxygenated water (120 mL).The 
aliquots (4 mL) was transferred to different stopper test tubes containing compound (50 and 
100 µM/mL) in  distilled alcohol. Control was prepared with distilled alcohol (1 mL) and 
emulsion (4 mL). BHA and ascorbic acid solution as internal standards of the same 
concentration were also analyzed for comparison. Zero adjustment was done using distilled 
water. Absorbance of the samples was measured at a wavelength of 470 nm, immediately 
(t=0), and subsequently after every 30 min for 3hr (t=180). The tubes were placed in a water 
bath at 500C between the readings. Antioxidant activities (AA) of each compound were 
evaluated in triplicates in terms of photooxidation of β-carotene using the following formula: 
         AA= 100 [1- (Ao – At / Aoo - Aot)] 
                       Where,   AA = Antioxidant Activity. 
                                     Ao  = Initial absorbance of the sample. 
                                     At  = Absorbance of the sample after time‘t’. 
                                     Aoo = Initial absorbance of the control. 
                                     Aot  = Absorbance of control after time‘t’. 
Reducing power assay (Iron reducing activity) 
The reducing power of synthesized compounds was determined according to the method of 
Oyaizu14. The compounds having 50 µM and 100 µM were mixed with 2.5 mL of phosphate 
buffer (0.2 M, pH 6.6) and 2.5 mL of 1% potassium ferric cyanide, and then incubated at 
500C for 20 min. To this mixture 2.5 mL of 10% trichloroacetic acid was added and the 
mixture was centrifuged at 3000 rpm for 20 min. The upper layer (2.5 mL) was mixed with 
2.5 mL of distilled water and 0.5 mL of 0.1% ferric chloride and the absorbance was taken at 
700nm. Increased absorbance of the reaction mixture indicates an increased reducing power 
Evaluation of antioxidant capacity by phosphomolybdenum method 
The total antioxidant capacity was evaluated by the method of Prieto et al15. An aliquot of    
0.1 mL of compound solutions (50 µM, 100 µM) was combined with 1 mL of reagent solution 
(0.6 M sulfuric acid, 28 mM sodium phosphate and 4mM ammonium molybdate). In case of 
blank 0.1 mL of methanol was used in place of compound. The tubes were capped and 
incubated in a boiling water bath at 950C for 90 min. After the  samples  had  cooled to RT, the  
absorbance of the aqueous solution of each was measured at 695 nm against blank in 
spectrophotometer. For compound of unknown composition, antioxidant capacity was 
expressed as equivalent of ascorbic acid (µM/mg of compound). 
Statistical analysis 
Tests were carried out in triplicates. The amount of compound needed to inhibit free radicals 
concentration by 50% (IC50) was graphically estimated using a linear regression algorithms. 
Results and Discussion 
DPPH radical scavenging activity 
The scavenging effects of all of the synthesized compounds on the DPPH free radical were 
evaluated. Now-a-days, antioxidants that exhibit DPPH radical scavenging activity are 
increasingly receiving attention. The  model of  scavenging  of  the  stable  DPPH  radical  is 
extensively used to evaluate radical scavenging activities in  less  time  than  other  
methods.Compound reacts with DPPH, which is a nitrogen centered radical with a  characteristic  
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absorption at 517 nm, and convert it to stable diamagnetic molecule 1,1-diphenyl-picryl 
hydrazine, due to its hydrogen donating ability at a very rapid rate16. When this electron becomes 
paired off, the absorption decreases stoichiometrically with respect to the number of electrons 
taken up. Such a change in the absorbance produced in this reaction has been widely applied to 
test the capacity of numerous molecules to act as free radical scavengers18. The six synthesized 
compounds scavenged DPPH radical significantly   in a concentration-dependent manner.  
 The radical scavenging activities of the synthesized compounds are summarized in 
Table 1. Compounds a and d showed appreciable radical scavenging activity. The presence of 
N-H group which can donate hydrogen atom in compound a moiety may contribute to the 
radical scavenging activity. The N-H group does have the radical scavenging property as the N 
protected compound19. The presence of the electron donating -OCH3 group at the 11th position 
of the seven member ring with N-H group may also contribute for better activity than 
dibenz[b,f]azepine whereas, the presence of carbonyl group in the other compounds  b, c, e, f   
may hinder the scavenging ability and shows negligible scavenging activity over DPPH. The 
presence of methoxy group in the seven member ring may enhance the stability of the nitrogen 
centered radical due to electron conjugation effect. 50% Inhibition concentration (IC50) for the 
synthesized compounds and the standards were calculated from the Table compound a and d 
displayed better activity than the standards.        
Table 1. Radical scavenging activity (%) of dibenz[b,f]azepine and its derivatives. each 
value represents means ± SD (n=3) 
β-Carotene- linoleic acid model system 
This method is based on the determination of the coupled oxidation of carotene and linoleic acid. 
The basic principle involved is that linoleic acid, unsaturated fatty acids get oxidized by reactive 
oxygen species (ROS) produced by oxygenated water. The products formed initiate the β-carotene 
oxidation, which leads to discoloration. Bleaching of β-carotene a free radical mediated 
phenomenon resulting from hyperoxides formed from linoliec acid. The six synthesized compounds 
scavenged DPPH radical significantly in a concentration-dependent manner. β-Carotene looses its 
double bonds by oxidation which results in lose of its characteristic orange colour monitored 
spectrophotometrically at 470 nm. Bleaching of β-carotene with respect to time of synthesized 
compounds at different concentrations are represented in Figure 1. The Figure indicates that due to 
the oxidation of linoleic acid which eventually attacks the highly unsaturated β-Carotene molecule 
undergo rapid discoloration, compound b, c, e, f looses its chromophore when it allowed for 
oxidation during different time interval (0-180 min). Initially the absorbance of the compounds was 
more and decreased drastically with in the time allowed for oxidation, but in case of compound a 
and d there is negligible decrease in the absorbance was observed. 
                                            RSA, %    
Compound 
     name 
                                  Concentration, µM 
       10                  50                100                  200                500 
IC50    
µM/mL
 
a 52.86±0.64  71.51±0.92 80.76±1.02 85.44±1.10 91.94±0.32 4.46 
b 0.97±0.44 1.72±1.22 2.25±0.54 7.38±0.98 9.37±0.33 270.10 
c 0.11±1.29 0.35±1.20 0.54±1.22 1.60±1.34 4.38±0.13 187.26 
d 69.60±0.18 78.25±0.34 86.03±0.82 92.22±1.45 95.71±0.11 2.10 
e 4.19±1.23 6.38±1.22 6.62±1.32 12.50±2.34 13.89±1.37 197.32 
f 0.21±1.78 0.35±1.39 0.54±1.44 1.79±1.19 4.38±1.87 187.26 
AA 45.64±0.67 62.61±0.39 75.66±0.98 81.55±0.21 84.39±0.10 4.94 
BHA 45.81±0.99 68.23±1.00 73.76±0.22 77.30±0.11 83.53±0.12 5.26 
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Figure 1.  Absorbance change of β-carotene at 470 nm in the presence of compounds a to f, 
control and positive control (BHA, AA). Each value represents means ± SD (n=3) 
 The control (no additive) are decolourised within 150 min, indicating that rapid 
oxidation occurred. The addition of compounds a to f and positive controls (BHA and AA) 
at different concentrations enhanced the bleaching time of β-Carotene. 
 The presence of antioxidant compounds a and d, binds the extent of β-Carotene 
bleaching by neutralizing the linoleate free radical; hence extent of decrease in discoloration 
indicates higher antioxidant activity.  
 The antioxidant activity for dibenz[b,f]azepine and its five derivatives was calculated 
and the percentage activities are as shown in  Figure 2.The Figure indicates that there is 
significant difference in the activity (%) at different concentrations. It was observed that the 
antioxidant activities (%) of all the compounds increase with increase in concentrations. 
 This effect of concentration on antioxidant activity becomes more pronounced as the 
time allowed for oxidation increases. The antioxidant activities of compounds were 
compared to the standards (BHA, ascorbic acid) and the compounds b, c, e, f possess less 
antioxidant  activity  but  compound a  and d  showed  promising  antioxidants. Also  the  
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antioxidant activity of a and d remained stable even with the time increase  allowed for 
oxidation, where as b, c, e, f decreased drastically as the time of oxidation increased. This 
was particularly noticeable at lower concentration (50 µM). This is because compound a 
contains free amino group (N-H bond) which can quenches the radical. The introducing of 
electron-with drawing group (-OCH3) on the seven membered ring of the compound a leads 
considerable increase in the scavenging activity. Where as in the case of compound b, c, e, f 
the presence of carbonyl group may hinder the antioxidant capacity. Hence in this assay 
compound a and d increases and stabilizes the antioxidant activity compared to other 
compounds. The activity was also compared to the commercial synthetic standards like 
BHA, ascorbic acid. From the comparison compound a and d showed equal and even more 
DPPH radical scavenging activity. 
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Figure 2.  Antioxidant activity (%) of the dibenz[b,f]azepine and its derivatives at 50 µM 
and 100 µM concentration in β-Carotene-Linoleic acid system. Values are means of 
triplicate determination ± standard deviation.  
Reducing power assay 
Reducing power of dibenz[b,f]azepine and its five derivatives at different concentration (25 
µM, 50 µM, 100 µM and 200 µM) was determined. In this assay, depending on the reducing 
power of antioxidant compounds the test solutions changes into various shades of green and 
blue colors. The reducing capacity of a compound may serve as a significant indicator of its 
potential antioxidant activity. The reduction of ferricyanide (Fe3+) complex to the ferrous 
(Fe2+) form can be monitored by measuring the formation of Perl’s Prussian blue at 700 nm  
which occurs in the presence of reductants (antioxidant compounds). Reducing power of the 
dibenz[b,f]azepine, its derivatives and standards (BHA and  ascorbic acid)  using the potassium 
ferricyanide reduction method were depicted in Figure 3. Compound a, d possess good 
reducing power ability compared to the other compounds. The Figure indicates that the 
compound a having free N-H group reduces free radicals but compound d having methoxy 
group in addition to N-H group reduces considerably more than compound a. These two 
compounds may react with free radicals to convert them to more stable products and terminate 
radical chain reaction. The presence of carbonyl group in the compound (b, c, e and f) may 
hinder the reduction of Fe3+ to Fe2+ and shows the negligible reducing ability. In general, the 
reducing power observed in the present study was in the following order compound d > 
compound a > BHA > ascorbic acid > compound b, c and e. The data presented here indicate 
that the marked reducing power of compound a and d seems to be the result of their 
antioxidant activity.  
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Figure 3. Antioxidant activity of the dibenz[b,f]azepine and its derivatives at different 
concentrations using reducing power assay. Each value represents means ± SD (n=3). High 
absorbance at 700 nm indicates high reducing power 
 The reducing power of the internal standards (BHA, ascorbic acid) was also carried out 
and comparative study over the synthesized compounds was done. Compound a and d 
shows promising activity than the internal standards.   
Evaluation of antioxidant capacity by phosphomolybdenum method 
The antioxidant activity for the synthesized compounds was evaluated by using phospho-
molybdate method. It determines the total antioxidant capacity. This assay is based on the 
reduction of Mo(VI) to Mo(V) in presence of the antioxidant compounds and the subsequent 
formation of a green phosphate/Mo(V) complex at acidic pH, which is measured at 695 
nm.The antioxidant capacity of the compounds was determined for 25 µM, 50 µM and 100 
µM concentrations. The antioxidant capacities of the compounds determined by 
phosphomolybdate method was expressed as µM of ascorbic acid equivalent/mg and showed 
in the Figure 4 
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Figure 4. Antioxidant capacities of dibenz[b,f]azepine and its derivatives by 
phosphomolybdate method. Each value represents means ± SD (n=3) 
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 From the Figure compound a showed good antioxidant capacity whereas compounds b, c, 
e and f having carbonyl group may hinder the reducing ability and shows less antioxidant 
capacity. Compound d reduces Mo(VI) to Mo(V) in better way due to the presence of -OCH3 
group in addition to N-H group shows the better activity than compound a. The antioxidant 
activity of the compounds were compared to standards (BHA and ascorbic acid) and found that 
compound a and d possess better phosphomolybdate activity than the standards. 
Conclusions 
Dibenz[b,f]azepine and its five analogues were successfully synthesized from the known 
methods and the antioxidant activity for the synthesized compounds was evaluated. The 
results of the present experiment shows that compound a and d showed more promising 
antioxidant activity against DPPH radical scavenging activity, reducing power assay,            
β-carotene-linoleic acid model system and phosphomolybdate method. The most active 
compounds like dibenz[b,f]azepine and its derivative (10-Methoxy-5H-dibenz[b,f]azepine) 
have shown better antioxidant and radical scavengers compared to the standards like BHA 
and ascorbic acid. It is conceivable from the studies that the tricyclic amines i.e., dibenz[b,f] 
azepine and some of its analogues are effective in their antioxidant activity properties. This 
will provides the theoretical information for the medicinal development, and supplies some 
in vitro methods for quick-optimizing drugs, which can be useful for the potential source of 
synthetic antioxidant. 
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